dc.contributor.author | Pinarbasi, Binnur | |
dc.contributor.author | Badur, Selim | |
dc.contributor.author | Kaymakoglu, Sabahattin | |
dc.contributor.author | Demir, Kadir | |
dc.contributor.author | Besisik, Fatih | |
dc.contributor.author | Gulluoglu, Mine | |
dc.contributor.author | Sumnu, Abdullah | |
dc.contributor.author | Akyuz, Filiz | |
dc.contributor.author | Baran, Bulent | |
dc.contributor.author | Gokturk, Suut | |
dc.contributor.author | Karaca, Cetin | |
dc.contributor.author | Ormeci, Asli | |
dc.contributor.author | Aydın, Yücel | |
dc.contributor.author | Soyer, Ozlem Mutluay | |
dc.contributor.author | Onel, Derya | |
dc.date.accessioned | 2021-03-03T15:58:21Z | |
dc.date.available | 2021-03-03T15:58:21Z | |
dc.identifier.citation | Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M. , Pinarbasi B., Gokturk S., Gulluoglu M., Onel D., Badur S., et al., "Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels", International Journal of Infectious Diseases, cilt.52, ss.68-73, 2016 | |
dc.identifier.issn | 1201-9712 | |
dc.identifier.other | av_41be6047-1b95-4f0f-bd64-82cdea869ecd | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/47929 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84993978170&origin=inward | |
dc.identifier.uri | https://doi.org/10.1016/j.ijid.2016.09.007 | |
dc.description.abstract | Objectives: Serum alanine aminotransferase (ALT) is a controversial marker for disease monitoring in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. The aim of this study was to determine the fibrosis stage and histological activity index (HAI) in HBeAg-negative CHB patients with persistently normal ALT (PNALT) and high serum HBV DNA (>= 2000 IU/ml) and to investigate clinical risk factors for the requirement of treatment through the examination of liver biopsy specimens. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | Yaşam Bilimleri | |
dc.title | Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels | |
dc.type | Makale | |
dc.relation.journal | International Journal of Infectious Diseases | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 52 | |
dc.identifier.startpage | 68 | |
dc.identifier.endpage | 73 | |
dc.contributor.firstauthorID | 236482 | |